NSRX

Nasus Pharma
NSRX

1 day
5 days
1 month
3 months
6 months
Year to date
1 year
5 years
10 years
 

About: Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

0
Funds holding %
of 7,476 funds
0
Analysts bullish %
of 1 analysts
0
Positive news %
of 3 articles
Price charts implemented using Lightweight Charts™